SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Psilocybin-induced stimulus control in the rat
16 references·2 citing·34 second hop
Psilocybin-induced stimulus control in the rat (2007)Psilocybin-induced stimulus control in th…Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Psilocybin can occasion mysti…Using Psilocybin to Investigate the Relationship between Attention, Working Memory, and the Serotonin 1A and 2A Receptors (2005)Using Psilocybin to Investiga…Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis (2005)Distinct temporal phases in t…Hallucinogens (2004)HallucinogensEffect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines (2000)Effect of Ring Fluorination o…Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d -methamphetamine in healthy volunteers (1999)Psychopathological, neuroendo…Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Psilocybin induces schizophre…TiHKAL: The Continuation (1997)TiHKAL: The ContinuationThe role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs I: Antagonist correlation analysis (1995)The role of the 5-HT2A and 5-…Do classical hallucinogens act as 5-HT2 agonists or antagonists? (1991)Do classical hallucinogens ac…Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes (1990)Differential interactions of …Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”) (1988)Serotonergic-dopaminergic med…The Botany and Chemistry of Hallucinogens. (1981)The Botany and Chemistry of H…The Botany and Chemistry of Hallucinogens (1974)The Botany and Chemistry of H…Comparison of the reactions induced by psilocybin and LSD-25 in man (1959)Comparison of the reactions i…Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen RauschpilzPsilocybe mexicana Heim (1958)Psilocybin, ein psychotroper …Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines (2008)Hallucinogens as discriminati…Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): Possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents (2007)Hallucinogen-like effects of …Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior (1983)The behavioral pharmacology of hallucinogens (2007)Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers (2011)Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms (2020)"Mysticism and Philosophy" (1960)Psychedelics (2016)Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial (2016)Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder (2020)Mysticism and Philosophy (2024)Das State-Trait-Angstinventar (STAI) : theoretische Grundlagen und Handanweisung (1981)Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens (1986)Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)Cardiovascular Effects of 3,4-Methylenedioxymethamphetamine: A Double-Blind, Placebo-Controlled Trial (2000)The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3, 4-methylenedioxymethamphetamine (‘Ecstasy’) in healthy volunteers (2000)Ayahuasca’s ‘afterglow’: improved mindfulness and cognitive flexibility in ayahuasca drinkers (2020)Effects of the 5-HT2A Agonist Psilocybin on Mismatch Negativity Generation and AX-Continuous Performance Task: Implications for the Neuropharmacology of Cognitive Deficits in Schizophrenia (2003)The Effects of the Preferential 5-HT2A Agonist Psilocybin on Prepulse Inhibition of Startle in Healthy Human Volunteers Depend on Interstimulus Interval (2007)Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults (2017)Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior (2007)Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later (2008)Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (2017)Bufo alvarius: a potent hallucinogen of animal origin (1994)Salvia divinorumand the Unique Diterpene Hallucinogen, Salvinorin (Divinorin) A (1994)Pharmahuasca: Human Pharmacology of Oral DMT Plus Harmine (1999)Hallucinogens and dissociative agents naturally growing in the United States (2004)Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant (2006)Exploring the therapeutic potential of Ayahuasca: acute intake increases mindfulness-related capacities (2015)Effects of psilocybin on hippocampal neurogenesis and extinction of trace fear conditioning (2013)The Therapeutic Potential of Psilocybin (2021)Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies (2017)Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness (2018)Human hallucinogen research: guidelines for safety (2008)Psychedelics Promote Structural and Functional Neural Plasticity (2018)REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics (2019)
this work references cited by second hop

References

  • 2006Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance1,682 cited
  • 2004Hallucinogens1,208 cited
  • 1998Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action1,015 cited
  • 1958Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen RauschpilzPsilocybe mexicana Heim280 cited
  • 1974The Botany and Chemistry of Hallucinogens255 cited
  • 2005Using Psilocybin to Investigate the Relationship between Attention, Working Memory, and the Serotonin 1A and 2A Receptors231 cited
  • 1997TiHKAL: The Continuation221 cited
  • 1990Differential interactions of indolealkylamines with 5-hydroxytryptamine receptor subtypes193 cited
  • 1981The Botany and Chemistry of Hallucinogens.193 cited
  • 1999Psychopathological, neuroendocrine and autonomic effects of 3,4-methylenedioxyethylamphetamine (MDE), psilocybin and d -methamphetamine in healthy volunteers145 cited
  • 1959Comparison of the reactions induced by psilocybin and LSD-25 in man140 cited
  • 1991Do classical hallucinogens act as 5-HT2 agonists or antagonists?137 cited
  • 1995The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs I: Antagonist correlation analysis136 cited
  • 2005Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

134 cited
  • 2000Effect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines131 cited
  • 1988Serotonergic-dopaminergic mediation of 3,4-methylenedioxymethamphetamine (MDMA, “ecstasy”)117 cited
  • Cited by

    • 2008Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines73 cited
    • 2007Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): Possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents70 cited